DAC
DGX icon

Dividend Assets Capital’s Quest Diagnostics DGX Stock Holding History

Dividend Assets Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-97
Closed -$15K – 518
2023
Q1 		$15K Hold
97
– – ﹤0.01% 396
2022
Q4 		$15K Hold
97
– – ﹤0.01% 396
2022
Q3 		$12K Hold
97
– – ﹤0.01% 431
2022
Q2 		$13K Hold
97
– – ﹤0.01% 437
2022
Q1 		$13K Hold
97
– – ﹤0.01% 415
2021
Q4 		$17K Hold
97
– – ﹤0.01% 386
2021
Q3 		$14K Hold
97
– – ﹤0.01% 400
2021
Q2 		$13K Hold
97
– – ﹤0.01% 406
2021
Q1 		$12K Hold
97
– – ﹤0.01% 423
2020
Q4 		$12K Buy
+97
New +$11.8K ﹤0.01% 423

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dividend Assets Capital's DGX Position: Q2 2023 in Review

Dividend Assets Capital sold out of Quest Diagnostics (DGX) in Q2 2023, closing a stake of 97 shares — an estimated $15K sold.

Dividend Assets Capital first reported a position in DGX in Q4 2020 and held it in 10 quarters. The position peaked at $17K in Q4 2021. 818 funds tracked by Wall St. Rank hold DGX as of Q2 2023.

  • Dividend Assets Capital reported no remaining Quest Diagnostics position as of Q2 2023 after selling out during the quarter.
  • Dividend Assets Capital sold 97 Quest Diagnostics shares in Q2 2023, an estimated $15K.
  • Dividend Assets Capital first reported a position in Quest Diagnostics in Q4 2020 and held it in 10 quarters.
  • Dividend Assets Capital's Quest Diagnostics position peaked at $17K in Q4 2021.
  • 818 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2023.

Based on Dividend Assets Capital's 13F filing for Q2 2023, filed 31 Jul 2023.